|
|
 Previous Article | Table of Contents | Next Article 
A Mutation of the Active Protein S Gene Leading to an EGF1-Lacking
Protein in a Family With Qualitative (Type II) Deficiency
C. Leroy-Matheron,
M. Gouault-Heilmann,
M. Aiach, and
S. Gandrille
From INSERM U.428, Paris, France; and the Laboratoire
d'Hémostase, Hôpital Henri Mondor, Créteil, France.
The genomic analysis of a 70-year-old man with recurrent deep venous
thrombosis having a protein S (PS)-deficient phenotype corresponding to
both type III and type II evidenced two different mutations: a +5
g a mutation in the donor splice site of intron e (ivs e) and
a ser 460 to Pro mutation. The propositus' son, who had a type II PS
deficiency phenotype, only bore the ivs e +5 ga mutation.
The study of platelet PS mRNA prepared from this subject showed that
the ivs e, +5 ga mutation led to the generation of two
abnormal transcripts, one lacking exon 5 and the other lacking exons 5 and 6. The presence of an additional PS band with a decreased molecular
mass on immunoblots performed in reducing conditions suggested the
presence of truncated PS lacking EGF1 (encoded by exon 5). Two
monoclonal antibodies (MoAbs) were used to further characterize the
nonfunctional plasma PS. Comparison of PS levels measured with each of
these MoAbs and PS levels in conventional assays was consistent with
the presence of an abnormal inactive protein in the plasma of both
patients bearing the ivs e, +5 ga mutation, suggesting that
variant PS lacking EGF1 is secreted but is devoid of activated protein
C cofactor activity.
Blood, Vol. 91 No. 12 (June 15), 1998:
pp. 4608-4615
© 1998 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. M. Rezende, R. E. Simmonds, and D. A. Lane
Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex
Blood,
February 15, 2004;
103(4):
1192 - 1201.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. R. Koenen, G. Tans, R. van Oerle, K. Hamulyak, J. Rosing, and T. M. Hackeng
The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation
Blood,
September 1, 2003;
102(5):
1686 - 1692.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. K. Giri, T. Yamazaki, N. Sala, B. Dahlback, and P. G. de Frutos
Deficient APC-cofactor activity of protein S Heerlen in degradation of factor Va Leiden: a possible mechanism of synergism between thrombophilic risk factors
Blood,
July 15, 2000;
96(2):
523 - 531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Espinosa-Parrilla, T. Yamazaki, N. Sala, B. Dahlback, and P. G. de Frutos
Protein S secretion differences of missense mutants account for phenotypic heterogeneity
Blood,
January 1, 2000;
95(1):
173 - 179.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. He, L. Shen, B. O. Villoutreix, and B. Dahlback
Amino Acid Residues in Thrombin-sensitive Region and First Epidermal Growth Factor Domain of Vitamin K-dependent Protein S Determining Specificity of the Activated Protein C Cofactor Function
J. Biol. Chem.,
October 16, 1998;
273(42):
27449 - 27458.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
